Correlation Between Madrigal Pharmaceuticals and UroGen Pharma
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and UroGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and UroGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and UroGen Pharma, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and UroGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of UroGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and UroGen Pharma.
Diversification Opportunities for Madrigal Pharmaceuticals and UroGen Pharma
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Madrigal and UroGen is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and UroGen Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UroGen Pharma and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with UroGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UroGen Pharma has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and UroGen Pharma go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and UroGen Pharma
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 1.7 times more return on investment than UroGen Pharma. However, Madrigal Pharmaceuticals is 1.7 times more volatile than UroGen Pharma. It trades about 0.22 of its potential returns per unit of risk. UroGen Pharma is currently generating about 0.01 per unit of risk. If you would invest 21,222 in Madrigal Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of 11,923 from holding Madrigal Pharmaceuticals or generate 56.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. UroGen Pharma
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| UroGen Pharma |
Madrigal Pharmaceuticals and UroGen Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and UroGen Pharma
The main advantage of trading using opposite Madrigal Pharmaceuticals and UroGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, UroGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UroGen Pharma will offset losses from the drop in UroGen Pharma's long position.| Madrigal Pharmaceuticals vs. TG Therapeutics | Madrigal Pharmaceuticals vs. Terns Pharmaceuticals | Madrigal Pharmaceuticals vs. Hepion Pharmaceuticals | Madrigal Pharmaceuticals vs. Viking Therapeutics |
| UroGen Pharma vs. Eliem Therapeutics | UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |